WPHM Insider Trading Activity and SEC Form 4 Filings
WPHM insider trading summary
No open-market insider purchases or sales of Winston Pharmaceuticals, Inc. (WPHM) have been reported on SEC Form 4 in the past 12 months.
Latest WPHM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 20, 2010 | Neal Stuart Penneys | Director | Buy | $4K (10,000 @ $0.40) |
| Jul 20, 2010 | Neal Stuart Penneys | Director | Buy | $4K (10,000 @ $0.44) |
| May 19, 2010 | Frost Gamma Investments Trust | 10% Owner | Sell | $0 (17,794,862 @ $0.00) |
| May 19, 2010 | Phillip Md Et Al Frost | 10% Owner | Sell | $0 (17,794,862 @ $0.00) |
| May 19, 2010 | Subbarao V Uppaluri | Director | Sell | $0 (209,449 @ $0.00) |
| May 19, 2010 | Joel E. Bernstein | President and CEO | Buy | $0 (18,399,271 @ $0.00) |
| Dec 16, 2009 | Phillip Md Et Al Frost | 10% Owner | Sell | $609 (1,741 @ $0.35) |
| Dec 16, 2009 | Frost Gamma Investments Trust | 10% Owner | Sell | $609 (1,741 @ $0.35) |
| Oct 16, 2009 | Scott B. Phillips | SVP, Scientific Affairs | Sell | $8K (13,500 @ $0.58) |
| Oct 16, 2009 | Scott B. Phillips | SVP, Scientific Affairs | Sell | $5K (6,500 @ $0.77) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.